After inducing ischemic AKI in 810-week-old, male C57BL/6 mice, mass spectrometry metabolomics revealed that the liver had the most distinct phenotype 24 h after AKI versus 4 h and 7 days
Variable Absorption : Oral administration may result in inconsistent bioavailability, affecting effectiveness or tolerability
10.1182/blood.v81.8.2150.bloodjournal8182150 Blood
Lindeboom L, Nabuurs CI, Hoeks J, Brouwers B, Phielix E, Kooi ME, et al
The standard protocol uses 2 to 3 mg GHK-Cu subcutaneously, five days per week, for 8 to 12 weeks
Management of Metabolic Conditions: For individuals with metabolic disorders, such as folate deficiency or conditions that affect B12 metabolism, B12 injections are often incorporated into treatment plans to optimize vitamin levels